Cargando…
VSEAMS: a pipeline for variant set enrichment analysis using summary GWAS data identifies IKZF3, BATF and ESRRA as key transcription factors in type 1 diabetes
Motivation: Genome-wide association studies (GWAS) have identified many loci implicated in disease susceptibility. Integration of GWAS summary statistics (P-values) and functional genomic datasets should help to elucidate mechanisms. Results: We extended a non-parametric SNP set enrichment method to...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296156/ https://www.ncbi.nlm.nih.gov/pubmed/25170024 http://dx.doi.org/10.1093/bioinformatics/btu571 |
_version_ | 1782352934989725696 |
---|---|
author | Burren, Oliver S. Guo, Hui Wallace, Chris |
author_facet | Burren, Oliver S. Guo, Hui Wallace, Chris |
author_sort | Burren, Oliver S. |
collection | PubMed |
description | Motivation: Genome-wide association studies (GWAS) have identified many loci implicated in disease susceptibility. Integration of GWAS summary statistics (P-values) and functional genomic datasets should help to elucidate mechanisms. Results: We extended a non-parametric SNP set enrichment method to test for enrichment of GWAS signals in functionally defined loci to a situation where only GWAS P-values are available. The approach is implemented in VSEAMS, a freely available software pipeline. We use VSEAMS to identify enrichment of type 1 diabetes (T1D) GWAS associations near genes that are targets for the transcription factors IKZF3, BATF and ESRRA. IKZF3 lies in a known T1D susceptibility region, while BATF and ESRRA overlap other immune disease susceptibility regions, validating our approach and suggesting novel avenues of research for T1D. Availability and implementation: VSEAMS is available for download (http://github.com/ollyburren/vseams). Contact: chris.wallace@cimr.cam.ac.uk Supplementary information: Supplementary data are available at Bioinformatics online. |
format | Online Article Text |
id | pubmed-4296156 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-42961562015-01-22 VSEAMS: a pipeline for variant set enrichment analysis using summary GWAS data identifies IKZF3, BATF and ESRRA as key transcription factors in type 1 diabetes Burren, Oliver S. Guo, Hui Wallace, Chris Bioinformatics Original Papers Motivation: Genome-wide association studies (GWAS) have identified many loci implicated in disease susceptibility. Integration of GWAS summary statistics (P-values) and functional genomic datasets should help to elucidate mechanisms. Results: We extended a non-parametric SNP set enrichment method to test for enrichment of GWAS signals in functionally defined loci to a situation where only GWAS P-values are available. The approach is implemented in VSEAMS, a freely available software pipeline. We use VSEAMS to identify enrichment of type 1 diabetes (T1D) GWAS associations near genes that are targets for the transcription factors IKZF3, BATF and ESRRA. IKZF3 lies in a known T1D susceptibility region, while BATF and ESRRA overlap other immune disease susceptibility regions, validating our approach and suggesting novel avenues of research for T1D. Availability and implementation: VSEAMS is available for download (http://github.com/ollyburren/vseams). Contact: chris.wallace@cimr.cam.ac.uk Supplementary information: Supplementary data are available at Bioinformatics online. Oxford University Press 2014-12-01 2014-08-27 /pmc/articles/PMC4296156/ /pubmed/25170024 http://dx.doi.org/10.1093/bioinformatics/btu571 Text en © The Author 2014. Published by Oxford University Press. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Papers Burren, Oliver S. Guo, Hui Wallace, Chris VSEAMS: a pipeline for variant set enrichment analysis using summary GWAS data identifies IKZF3, BATF and ESRRA as key transcription factors in type 1 diabetes |
title | VSEAMS: a pipeline for variant set enrichment analysis using summary GWAS data identifies IKZF3, BATF and ESRRA as key transcription factors in type 1 diabetes |
title_full | VSEAMS: a pipeline for variant set enrichment analysis using summary GWAS data identifies IKZF3, BATF and ESRRA as key transcription factors in type 1 diabetes |
title_fullStr | VSEAMS: a pipeline for variant set enrichment analysis using summary GWAS data identifies IKZF3, BATF and ESRRA as key transcription factors in type 1 diabetes |
title_full_unstemmed | VSEAMS: a pipeline for variant set enrichment analysis using summary GWAS data identifies IKZF3, BATF and ESRRA as key transcription factors in type 1 diabetes |
title_short | VSEAMS: a pipeline for variant set enrichment analysis using summary GWAS data identifies IKZF3, BATF and ESRRA as key transcription factors in type 1 diabetes |
title_sort | vseams: a pipeline for variant set enrichment analysis using summary gwas data identifies ikzf3, batf and esrra as key transcription factors in type 1 diabetes |
topic | Original Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296156/ https://www.ncbi.nlm.nih.gov/pubmed/25170024 http://dx.doi.org/10.1093/bioinformatics/btu571 |
work_keys_str_mv | AT burrenolivers vseamsapipelineforvariantsetenrichmentanalysisusingsummarygwasdataidentifiesikzf3batfandesrraaskeytranscriptionfactorsintype1diabetes AT guohui vseamsapipelineforvariantsetenrichmentanalysisusingsummarygwasdataidentifiesikzf3batfandesrraaskeytranscriptionfactorsintype1diabetes AT wallacechris vseamsapipelineforvariantsetenrichmentanalysisusingsummarygwasdataidentifiesikzf3batfandesrraaskeytranscriptionfactorsintype1diabetes |